Fixed Drug Eruption
An Underrecognized Cutaneous Adverse Drug Reaction in a 7-Year-Old Male - A Case Report
DOI:
https://doi.org/10.70552/pjaai.26.2.18200Keywords:
fixed drug eruption, adverse drug reaction, paracetamol, drug hypersensitivity, case reportAbstract
Fixed drug eruptions (FDEs) are a distinctive delayed hypersensitivity reaction characterized by recurrent lesions at the same anatomical sites upon re-exposure to the culprit drug. Although paracetamol is widely used and generally considered safe at therapeutic doses, paracetamol-induced FDE is uncommon and often underrecognized. We report a case of a 7-year-old Filipino male with no history of atopy who developed recurrent episodes of pruritic, well-demarcated erythematous patches that consistently appeared within minutes after paracetamol intake and evolved into persistent hyperpigmented lesions at identical sites. Physical examination revealed multiple well-demarcated hyperpigmented patches without mucosal involvement. A supervised one-step oral paracetamol challenge at a low weight-based dose (10 mg/kg) reproduced pruritus and erythema over pre-existing lesions within 10 minutes, confirming the diagnosis of paracetamol-induced fixed drug eruption. This case emphasizes that paracetamol can cause FDE in children, highlighting the importance of recognizing lesion recurrence patterns, confirming diagnosis through a supervised challenge when appropriate, and ensuring avoidance of the offending drug with counseling on safe alternatives to prevent recurrence.
References
1. Ardern-Jones M. Common cutaneous drug reactions. BMJ Best Practice. 2024. Accessed February 15, 2026. https://bestpractice.bmj.com/topics/en-gb/368
2. Gosiengfiao V, Alberto N. Cutaneous drug reactions and their causative agents as seen at the Philippine General Hospital Section of Dermatology from January 2001 to March 2003. J Philipp Dermatol Soc. 2005;14(1):49-52.
3. Heelan K, Shear NH. Cutaneous drug reactions in children: an update. Paediatr Drugs. 2013;15(6):493-503. https://pubmed.ncbi.nlm.nih.gov/23842849 https://doi.org/10.1007/s40272-013-0039-z
4. Khaled A, Kharfi M, Hamida MB, et al. Cutaneous adverse drug reactions in children. A series of 90 cases. Tunis Med. 2012;90(1):45-50. https://pubmed.ncbi.nlm.nih.gov/22311448
5. Dilek N, Ozkol H, Akbaş A, et al. Cutaneous drug reactions in children: A multicentric study. Postepy Dermatol Alergol. 2014;31(6):368-71. https://pubmed.ncbi.nlm.nih.gov/25610351 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4293388 https://doi.org/10.5114/pdia.2014.43881
6. McClatchy J, Yap T, Nirenberg A, Scardamaglia L. Fixed drug eruptions – the common and novel culprits since 2000. J Dtsch Dermatol Ges. 2022;20(10):1289-1302. https://pubmed.ncbi.nlm.nih.gov/36210056 https://doi.org/10.1111/ddg.14870
7. Shaker G, Mehendale T, De La Rosa C. Fixed drug eruption: an underrecognized cutaneous manifestation of a drug reaction in the primary care setting. Cureus. 2022;14(8):e28299. https://pubmed.ncbi.nlm.nih.gov/36034061 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9397151 https://doi.org/10.7759/cureus.28299
8. Heng YK, Yew YW, Lim DS, Lim YL. An update of fixed drug eruptions in Singapore. J Eur Acad Dermatol Venereol. 2015;29(8):1539-44. https://pubmed.ncbi.nlm.nih.gov/25491106 https://doi.org/10.1111/jdv.12919
9. Thompson G, Bundell C, Lucas M. Paracetamol allergy in clinical practice. Aust J Gen Pract. 2019;48(4):216-9. https://pubmed.ncbi.nlm.nih.gov/31256492 https://doi.org/10.31128/AJGP-08-18-4689
10. Popiołek I, Piotrowicz-Wójcik K, Porebski G. Hypersensitivity reactions in serious adverse events reported for paracetamol in the EudraVigilance Database, 2007-2018. Pharmacy (Basel). 2019;7(1):12. https://pubmed.ncbi.nlm.nih.gov/30658389 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6473647 https://doi.org/10.3390/pharmacy7010012
11. Fathallah N, Ben Salem C, Slim R, Boussofara L, Ghariani N, Bouraoui K. Acetaminophen-induced cellulitis-like fixed drug eruption. Indian J Dermatol. 2011;56(2):206-8. https://pubmed.ncbi.nlm.nih.gov/21716550 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108524 https://doi.org/10.4103/0019-5154.80419
12. Sá L, Leitão C, Romariz J, Costa H, Praça F, Pedrosa C. Fixed drug eruption induced by paracetamol – a case report. Acta Sci Paediatr. 2020;3(12):27-9. https://doi.org/10.31080/ASPE.2020.03.0329
13. Shiohara T. Fixed drug eruption: pathogenesis and diagnostic tests. Curr Opin Allergy Clin Immunol. 2009;9(4):316-21. https://pubmed.ncbi.nlm.nih.gov/19474709 https://doi.org/10.1097/ACI.0b013e32832cda4c
14. Phyo YM, Kogilwaimath SK, Chu YF. Paracetamol induced fixed drug eruption in a child. Brunei Int Med J. 2025;21(5):49- 52. https://moh.gov.bn/wp-content/uploads/2025/06/BIMJ2025-21-1-49-52-CR-PCM-fixed-drug-eruption.pdf
15. Pellicano R, Ciavarella G, Lomuto M, Di Giorgio G. Genetic susceptibility to fixed drug eruption: evidence for a link with HLA-B22. J Am Acad Dermatol. 1994;30(1):52-4. https://pubmed.ncbi.nlm.nih.gov/8277031 https://doi.org/10.1016/s0190-9622(94)70007-9
16. Rutkowski K, Nasser SM, Ewan PW. Paracetamol hypersensitivity: clinical features, mechanism and role of specific IgE. Int Arch Allergy Immunol. 2012;159(1):60-4. https://pubmed.ncbi.nlm.nih.gov/22555261 https://doi.org/10.1159/000335213
17. Nino M, Francia MG, Costa C, Scalvenzi M. Bullous fixed drug eruption induced by paracetamol: report of a pediatric case. Case Rep Dermatol. 2009;1(1):56-9. https://pubmed.ncbi.nlm.nih.gov/20652116 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2895212 https://doi.org/10.1159/000243728
18. Jain A, Khaire P, Pawar S, Bhandhekar J. Fixed drug eruption induced by paracetamol: uncommon reaction to a common drug. Int J Med Sci Curr Res. 2023;6(3):135-8.
19. Lee AY. Fixed drug eruptions. Incidence, recognition, and avoidance. Am J Clin Dermatol. 2000;1(5):277-85. https://pubmed.ncbi.nlm.nih.gov/11702319 https://doi.org/10.2165/00128071-200001050-00003
20. Kidon M, Blanca-Lopez N, Gomes E, et al. EAACI/ENDA position paper: diagnosis and management of hypersensitivity reactions to non-steroidal anti-inflammatory drugs (NSAIDs) in children and adolescents. Pediatr Allergy Immunol. 2018;29(5):469-80. https://pubmed.ncbi.nlm.nih.gov/29693290 https://doi.org/10.1111/pai.12915
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Rex David N. Nuico, MD, DPPS , Agnes G. Andaya, MD, FPPS, FPSAAI

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.